某院儿科2010年抗生素相关腹泻临床分析  

Analysis of Antibiotic-associated Diarrhea in Pediatric of Hospital during 2010

作　　者：彭淑峰 王芸 张晓红 

机构地区：[1]陕西省博爱医院,陕西西安710065 [2]西安陆军学院门诊部,陕西西安710108

出　　处：《吉林医学》2011年第15期3003-3005,共3页Jilin Medical Journal

摘　　要：目的:提高对抗生素应用过程中导致婴幼儿抗生素相关腹泻的认识,并探讨其防治方法。方法:抽取应用抗生素治疗的全部住院病历,按抗生素相关腹泻的诊断标准,统计分析其发病率,探讨其发病原因,提出防治办法。结果:抗生素相关腹泻总发病率为10.8%,其中头孢呋辛占7.6%;头孢曲松占1.2%;克林霉素占0.8%;两联以上抗生素占1.3%。应用微生态制剂及肠黏膜保护剂,佐以免疫增强剂静脉用人血免疫球蛋白(IVIG),防治疗效满意。结论:儿科抗生素相关腹泻发病率较高,受多种因素影响,可用微生态制剂及免疫增强剂防治。Objective To enhance the recognition of antibiotic-associated diarrhea in the process of using antibiotic and research the method of prevention and treatment.Methods Acording to the diagnosis standards of antibiotic-associated diarrhea,all inpatients with antibiotic treatment in pediatrics was chosen.Through analysis the incidence rate of antibiotic-associated diarrhea,the reasons and preventive measures were proposed.Results The total incidence rate of antibiotic-associated diarrhea in the pediatrics was 10.8%.The curative effect of diarrhea treated with dertinent drugs was satisfactory.Conclusion The incidence rate of antibiotic-associated diarrhea in pediatrics was high and related with many factors.The microecosystem,bowl mucosa protective agents and human immunoglobulin for intravenous injection can prevent and cure antibiotic-associated diarrhea.

关 键 词：抗生素 抗生素相关腹泻(AAD) 微生态制剂 肠黏膜保护剂 

分 类 号：R725.9[医药卫生—儿科]